HLA-B8, DR3: A new risk factor for graft failure after renal transplantation in patients with underlying immunoglobulin a nephropathy

Clinical Transplantation

Volumn 23, Issue 5, 2009, Pages 660-665

  Andresdottir, Margret B ^a   Haasnoot, Geert W ^b   Persijn, Guido G ^c   Claas, Frans H J ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

Author keywords

DR3; Graft survival; HLA B8; IgA nephropathy; IgAN; Renal transplantation; Risk factor

Indexed keywords

HLA B8 ANTIGEN; HLA DR3 ANTIGEN; IMMUNOGLOBULIN A;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GRAFT FAILURE; GRAFT SURVIVAL; HAPLOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME;

FEMALE; GENOTYPE; GLOMERULONEPHRITIS, IGA; GRAFT REJECTION; HAPLOTYPES; HLA-B8 ANTIGEN; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; REGISTRIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70350148345     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01059.x     Document Type: Article

References (23)

1. Aly TA, Eller E, Ide A. Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes 2006, 55:1265.
2. Price P, Witt C, Allcock R. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999, 167:257.
3. Candore G, Modica MA, Lio D. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed Pharmacother 2003, 57:274.
4. Lietz K, John R, Burke E. Increased risk for cardiac allograft rejection in recipients with HLA-B8, DR3 type. Transplant Proc 2001, 33:481.
5. Doran TJ, Geczy AF, Painter D. A large, single center investigation of the immunogenetic factors affecting liver transplantation. Transplantation 2000, 69:1491.
6. Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF. Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol 2001, 56:279.
7. Andresdottir MB, Haasnoot GW, Doxiadis II, Persijn GG, Claas FH. Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: a retrospective analysis of registry data. Transplantation 2005, 80:1012.
8. Lim ECTP. High survival rate of kidney transplants in IgA nephropathy patients. Clin Transplant 1992, 6:100.
9. Doxiadis II, De Lange P, De Vries E, Persijn GG, Claas FH. Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure. Tissue Antigens 2001, 57:344.
10. Lio D, D'Anna C, Leone F, Curro MF, Candore G, Caruso C. Hypothesis: interleukin-5 production impairment can be a key point in the pathogenesis of the MHC-linked selective IgA deficiency. Autoimmunity 1998, 27:185.
11. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993, 177:557.
12. Lio D, Candore G, Colombo A. A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity. Hum Immunol 2001, 62:705.
13. Lawley TJ, Hall RP, Fauci AS, Katz SI, Hamburger MI, Frank MM. Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects. N Engl J Med 1981, 304:185.
14. Caruso C, Candore G, Modica MA. Major histocompatibility complex regulation of cytokine production. J Interferon Cytokine Res 1996, 16:983.
15. Colucci AT, Di Lorenzo G, Ingrassia A. Blood antiphospholipid antibody levels are influenced by age, sex and HLA-B8,DR3 phenotype. Exp Clin Immunogenet 1992, 9:72.
16. Poli F, Boschiero L, Giannoni F. Tumour necrosis factor-alpha gene polymorphism: implications in kidney transplantation. Cytokine 2000, 12:1778.
17. Sankaran D. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999, 56:281.
18. Hahn AB, Kasten-Jolly JC, Constantino DM. TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome. Transplantation 2001, 72:660.
19. Pawlik A, Domanski L, Rozanski J. IL-2 and TNF-alpha promoter polymorphisms in patients with acute kidney graft rejection. Transplant Proc 2005, 37:2041.
20. Cicciarelli JC, Perdue S, Terasaki PI. HLA-DR3 associated with improved kidney transplant survival. Transplant Proc 1982, 14:308.
21. Ross W, Solomon H, Reese J, Fairchild R, Garvin P, Kurtz M. Beneficial effects of HLA-DR3 gene expression on renal allograft survival in black recipients. Transplant Proc 1993, 25:2408.
22. Ngcobo TK, Becker P, Modiba MC. Effect of HLA-DR3 gene expression on cadaveric renal allograft survival in blacks. Clin Transplant 1996, 10:60.
23. Krishnan G, Thacker L, Capelli J. Is HLA-DR3 phenotype beneficial for renal allograft survival?. Transpl Immunol 1999, 7:183.